deltatrials
Completed PHASE2 NCT00003445

Docetaxel in Treating Patients With Advanced Cancer of the Cervix

Neoadjuvant Chemotherapy With Docetaxel in Advanced Cervical Carcinoma

Sponsor: Grupo Oncologico Cooperativo del Sur

Conditions Cervical Cancer
Interventions docetaxel
Updated 6 times since 2017 Last updated: Jun 25, 2013 Started: Dec 31, 1997 Completion: Apr 30, 2004

A PHASE2 clinical study on Cervical Cancer, this trial is completed. The trial is conducted by Grupo Oncologico Cooperativo del Sur and has accumulated 6 data snapshots since 1997. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Change History

6 versions recorded

  1. Sep 2025 — Present [monthly]

    Completed PHASE2

  2. Sep 2024 — Sep 2025 [monthly]

    Completed PHASE2

  3. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE2

  4. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE2

  5. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE2

▶ Show 1 earlier version

  1. Jan 2017 — Jun 2018 [monthly]

    Completed PHASE2

    First recorded

Dec 1997

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Grupo Oncologico Cooperativo del Sur
Data source: National Cancer Institute (NCI)

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Neuquén, Argentina